Saudi Healthtech Aumet Secures $12 Million Series A To Expand AI Procurement Platform

Saudi Arabia-based healthtech Aumet has raised $12 million in a Series A funding round to scale its AI-powered procurement operating system for healthcare providers. The round was led by Emkan Capital, with significant participation from both regional and international investors.

Quick Facts

• Funding: $12 million Series A round
• Lead Investor: Emkan Capital
• Mission: To build an AI-powered OS for healthcare supply chains
• Traction: $1 billion in GMV across 12,000+ pharmacies

From Marketplace to AI Operating System

Founded in 2016 by Yahya Aqel, Adel Haddad, and Shahed Jaber, Aumet has built a platform processing over five million transactions annually and connecting more than 1,000 pharmaceutical suppliers. The company has moved beyond a simple marketplace model to offer a multi-layered operating system.

Its product suite includes:

• Pulse: A cloud-based system for individual pharmacies that integrates inventory management, a marketplace, and AI-driven procurement automation.
• Chain: A solution for pharmacy chains that enables centralized purchasing and decision-making across multiple branches.
• Enterprise: An AI-powered cognitive procurement system designed for large-scale operations like hospitals, ministries of health, and national healthcare systems.

The Enterprise solution has already been deployed across 32 hospitals and over 500 medical centers in Jordan, including at Al-Basheer Hospital, the country’s largest. This rollout was conducted in collaboration with Jordan’s Ministry of Health and Presight, an Abu Dhabi-based AI company.

Backing from Regional and Global VCs

Emkan Capital led the investment, joined by new backers Qatar Development Bank (QDB), SABAH VC, and AAIC. The round also saw follow-on investment from existing investors Shorooq Partners and Right Side Capital Management, alongside strategic players from the healthcare sector like Cigalah Group and Salehiya Trading Company.

“Aumet is building what we believe is the foundational operating system for healthcare supply chains in emerging markets,” commented a representative from Emkan Capital.

Abbas Kazmi of SABAH.fund added, “Aumet exemplifies the kind of founder-market fit we look for, combining deep expertise and regional insight with scalable, technology-driven solutions and we are excited to support their journey towards becoming a category leader.”

Tackling Healthcare Inefficiencies

Aumet aims to solve deep-rooted inefficiencies in a sector that often relies on disconnected, legacy systems. By connecting pharmacies, hospitals, and suppliers on a single digital platform, it provides the data intelligence needed for smarter procurement.

“Healthcare supply chains don’t suffer from lack of supply — they suffer from lack of intelligence,” said Yahya Aqel, CEO and Co-founder of Aumet. “At Aumet, we are building the AI-first operating system that powers procurement decisions across the entire healthcare ecosystem — from individual pharmacies to national healthcare systems. Our ambition is to take what we’ve built in the Middle East and scale it globally.”

What’s Next for Aumet

With the new capital, Aumet plans to enhance its AI capabilities, expand its Enterprise deployments with larger healthcare networks, and scale its Pulse solution for pharmacies globally. The company is also focused on entering new markets across the GCC and other international territories.

About Aumet

Founded by Yahya Aqel, Adel Haddad, and Shahed Jaber, Aumet develops an AI-first procurement operating system for the healthcare industry. Its platform connects pharmacies, hospitals, and suppliers to streamline inventory management, procurement, and data-driven decision-making across the supply chain. The company operates in Saudi Arabia, Jordan, and Egypt.

Source: Wamda